DRAK2 aggravates nonalcoholic fatty liver disease progression through SRSF6-associated RNA alternative splicing. Li yufeng, et al.
Published: 6 October 2021| Version 1 | DOI: 10.17632/jdc7y9yvxf.1
Contributor:
Description
Raw data from the article CELL-METABOLISM-D-21-00185 Figures 1, 4-7, S1-S3 and S6-S7 were deposited in a separate zip file below.
Files
Categories
Database